Suppr超能文献

[系统性红斑狼疮患者中观察到的噬血细胞综合征]

[Hemophagocytic syndrome observed in a patient with systemic lupus erythematosus].

作者信息

Hayashi S, Nawata Y, Takabayashi K, Iwamoto I, Yoshida S

机构信息

Second Department of Internal Medicine, School of Medicine, Chiba University.

出版信息

Ryumachi. 1994 Aug;34(4):779-85.

PMID:7974030
Abstract

A 52-year-old woman was admitted to our hospital because of a skin rash, high fever and myalgia. She had been diagnosed ten years ago by a dermatologist as having MCTD (mixed connective tissue disease). At the time of admission a diagnosis of active SLE was made by fulfilling four of the 1982 ARA criteria together with increasing levels of anti-DNA antibody and low levels of complements. Prednisolone (PSL) given orally in an initial dosage of 60 mg/day was effective during the first 6 weeks. Then a high fever, skin rash and pancytopenia appeared without active findings of SLE. Infection caused by bacteria, fungus or virus was suspected, but no infectious agent was present in cultures derived from blood or other sources. Antimicrobic drugs used were not effective at all. The clinical picture was suggestive of a drug allergy, but no causative drug was found. A diagnosis of hemophagocytic syndrome (HPS) was made because of the increased number of unusual hemophagocytic cells in the bone marrow. High levels of serum ferritin and neopterin, which are known to reflect macrophage activation, supported the diagnosis of HPS. HPS is characterized by activated phagocytosis presumably induced by hypersecretion of cytokines. Malignant lymphoma and infection are the two representative diseases which may cause HPS. Recently, an acute lupus HPS was reported in patients with active SLE. Here we reported a case of reactive HPS observed in a patient with SLE who had been receiving high dose PSL. Symptoms and findings of the patient gradually disappeared in several weeks after rapid reduction of the PSL dose.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

一名52岁女性因皮疹、高热和肌痛入院。她十年前被皮肤科医生诊断为混合性结缔组织病(MCTD)。入院时,根据1982年美国风湿病学会(ARA)标准中的四项,同时结合抗DNA抗体水平升高和补体水平降低,诊断为活动性系统性红斑狼疮(SLE)。初始口服泼尼松龙(PSL)剂量为60mg/天,在最初6周有效。之后出现高热、皮疹和全血细胞减少,而无SLE的活动性表现。怀疑是由细菌、真菌或病毒引起的感染,但血液或其他来源的培养物中未发现感染病原体。使用的抗菌药物完全无效。临床表现提示药物过敏,但未发现致病药物。由于骨髓中异常噬血细胞数量增加,诊断为噬血细胞综合征(HPS)。已知反映巨噬细胞活化的血清铁蛋白和新蝶呤水平升高支持HPS的诊断。HPS的特征是可能由细胞因子过度分泌诱导的活化吞噬作用。恶性淋巴瘤和感染是可能导致HPS的两种代表性疾病。最近,有报道称活动性SLE患者出现急性狼疮性HPS。本文报告了1例在接受高剂量PSL的SLE患者中观察到的反应性HPS病例。在迅速降低PSL剂量后的几周内,患者的症状和体征逐渐消失。(摘要截短至250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验